Return to Vaccination News Home Page  __»   Right-click to "open in new window"

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

http://www.ivanhoe.com/channels/p_channelstory.cfm?storyid=6545

Reported July 10, 2003

Peanut Allergies may not be Permanent

(Ivanhoe Newswire) -- Scientists believe some children with peanut allergies may outgrow them over time. In a recent study completed at Johns Hopkins Children’s Center and Arkansas Children’s Hospital, researchers concluded, “Patients with a history of peanut allergy and peanut-IgE levels (the antibodies made by the immune system that cause allergic reactions) of five or less have at least a 50-percent chance of outgrowing their allergy.”

Researchers gave a group of 80 children, ages 4 to 14 years, with low levels of allergy antibodies, an oral peanut challenge. The patients were fed a peanut, and then closely monitored for common allergic reactions like coughing, hives, and difficulty breathing. Results of this study show that 55 percent of patients with peanut-IgE levels of five or less passed these challenges, implying that they may have outgrown their allergy.

Peanut allergies produce serious, even fatal reactions. They affect up to 2 percent of young children and 1.5 million Americans, and those numbers could be rising. This sensitive allergy can be set off by 1/1000th of a peanut; such trace amounts often found in prepared foods. Allergic reactions to peanuts can cause anaphylaxis, a condition that constricts the lungs, lowers blood pressure, causes swelling in the tongue and throat, and may lead to death.

Recurrence of this allergy may occur, but is uncommon. Researchers say, “Risk of recurrence may be higher among those who do not consume enough peanuts to maintain their tolerance level.” They also recommend patients with resolved peanut allergy should continue to carry epinephrine to prevent serious effects of recurrence. They also say further research should include tests on patients with peanut-IgE levels greater than five.

This article was reported by Ivanhoe.com, who offers a searchable archive of its medical reports written since 1995. To search, go to: http://www.ivanhoe.com/search/.

SOURCE: The Journal of Allergy and Clinical Immunology, 2003;112:183-189

Related Articles in Archives:
 
webdoctor@ivanhoe.com
Copyright © 2003 Ivanhoe Broadcast News, Inc.
2745 West Fairbanks Avenue
Winter Park, Florida 32789
(407) 740-0789

P.O. Box 865
Orlando, Florida 32802

 

Return to Vaccination News Home Page  __»   Right-click to "open in new window"

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.